Boehringer Ingelheim Pharma GmbH & Co KG, Biberach (Germany)
Contributor content
Event: Frontiers in CardioVascular Biology 2016
Topic: Miscellaneous
Session: Anticoagulants in cardiovascular disease – from basics to translation